Actively Recruiting
AI System for Detection and Characterization of Chronic Enteropathies
Led by Istituti Clinici Scientifici Maugeri SpA · Updated on 2026-02-04
380
Participants Needed
1
Research Sites
157 weeks
Total Duration
On this page
Sponsors
I
Istituti Clinici Scientifici Maugeri SpA
Lead Sponsor
F
Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
Collaborating Sponsor
AI-Summary
What this Trial Is About
Coeliac disease (CD) is an immune-mediated enteropathy leading to small intestinal mucosal atrophy. Diagnosis relies on serology and duodenal biopsies, but it can be complicated by patchy lesions and differential diagnosis with Non-Celiac Enteropathies (NCEs). This multicenter observational study aims to develop and validate an Artificial Intelligence (AI) system to detect and characterize small bowel mucosal atrophy and other pathological findings using endoscopic imaging. The study involves a retrospective phase for training the AI model and a prospective phase to validate its diagnostic accuracy compared to standard human assessment.
CONDITIONS
Official Title
AI System for Detection and Characterization of Chronic Enteropathies
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patients (age 18 years)
- Patients undergoing endoscopic investigation of the small bowel (endoscopy or capsule endoscopy)
You will not qualify if you...
- Inability to provide informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
ICS Maugeri IRCCS
Pavia, PV, Italy, 27100
Actively Recruiting
Research Team
F
Federico Biagi, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here